Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 2 institutions in 1 country.
Bruna Barbosa de SousaInstituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Carla Cristine Neves MamedeInstituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil.
Mariana Santos MatiasInstituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Déborah Fernanda da Cunha PereiraInstituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Mayara Ribeiro de QueirozInstituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil.ORCID 0000-0002-2628-844X
Edigar Henrique Vaz DiasInstituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Anielle Christine Almeida SilvaInstituto de Física, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Noelio Oliveira DantasInstituto de Física, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Júnia de Oliveira CostaInstituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.ORCID 0000-0002-8499-0376
Fábio de OliveiraInstituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil.ORCID 0000-0002-9166-3461
Universidade Federal de Uberlândia · BRInstituto Federal de Educação, Ciência e Tecnologia do Triângulo Mineiro · BR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
This work reports the purification and functional characterization of BmooPAi, a platelet-aggregation-inhibiting factor from
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A New Platelet-Aggregation-Inhibiting Factor Isolated from · full record | OpenQuestion